亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis

医学 心房颤动 内科学 超重 华法林 体质指数 荟萃分析 优势比 冲程(发动机) 随机对照试验 心脏病学 机械工程 工程类
作者
Aaqib H. Malik,Srikanth Yandrapalli,Suchith Shetty,Wilbert S. Aronow,Diwakar Jain,William H. Frishman,Howard A. Cooper,Julio A. Panza
出处
期刊:Europace [Oxford University Press]
卷期号:22 (3): 361-367 被引量:25
标识
DOI:10.1093/europace/euz361
摘要

This study sought to determine the impact of weight and body mass index (BMI) on the safety and efficacy of direct-acting oral anticoagulants (DOACs) compared with warfarin in patients with non-valvular atrial fibrillation.A systematic literature search was employed in PubMed, Embase, and Cochrane clinical trials with no language or date restrictions. Randomized trials or their substudies were assessed for relevant outcome data for efficacy that included stroke or systemic embolization (SSE), and safety including major bleeding and all-cause mortality. Binary outcome data and odds ratios from the relevant articles were used to calculate the pooled relative risk. For SSE, the data from the four Phase III trials showed that DOACs are better or similarly effective with low BMI 0.73 (0.56-0.97), normal BMI 0.72 (0.58-0.91), overweight 0.87 (0.76-0.99), and obese 0.87 (0.76-1.00). The risk of major bleeding was also better or similar with DOACs in all BMI subgroups with low BMI 0.62 (0.37-1.05), normal BMI 0.72 (0.58-0.90), overweight 0.83 (0.71-0.96), and obese 0.91 (0.81-1.03). There was no impact on mortality in all the subgroups. In a meta-regression analysis, the effect size advantage of DOACs compared with warfarin in terms of safety and efficacy gradually attenuated with increasing weight.Our findings suggest that a weight-based dosage adjustment may be necessary to achieve optimal benefits of DOACs for thromboembolic prevention in these patients with non-valvular atrial fibrillation. Further dedicated trials are needed to confirm these findings. PROSPERO 2019 CRD42019140693. Available from: https://www.crd.york.ac.uk/prospero/display_record.php? ID=CRD42019140693.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
Microbiota完成签到,获得积分10
22秒前
会飞的流氓兔完成签到 ,获得积分10
22秒前
32秒前
DL完成签到,获得积分10
34秒前
DL发布了新的文献求助10
39秒前
小马甲应助科研通管家采纳,获得10
49秒前
MchemG应助科研通管家采纳,获得100
49秒前
大模型应助科研通管家采纳,获得10
49秒前
李健的小迷弟应助xiongdi521采纳,获得10
50秒前
51秒前
闫雪发布了新的文献求助10
55秒前
1分钟前
橙子味的邱憨憨完成签到 ,获得积分10
1分钟前
xiongdi521发布了新的文献求助10
1分钟前
隐形曼青应助闫雪采纳,获得10
1分钟前
激动的似狮完成签到,获得积分10
1分钟前
1分钟前
1分钟前
Xw发布了新的文献求助10
1分钟前
Plum22发布了新的文献求助10
1分钟前
2分钟前
啊哦额发布了新的文献求助10
2分钟前
2分钟前
qq发布了新的文献求助10
2分钟前
Akitten完成签到,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
GingerF应助科研通管家采纳,获得10
2分钟前
GingerF应助科研通管家采纳,获得20
2分钟前
GingerF应助科研通管家采纳,获得10
2分钟前
酷波er应助科研通管家采纳,获得10
2分钟前
MchemG应助科研通管家采纳,获得30
2分钟前
大胆梦容关注了科研通微信公众号
2分钟前
Xw关闭了Xw文献求助
2分钟前
Plum22驳回了Lucas应助
3分钟前
李健的粉丝团团长应助kohu采纳,获得10
3分钟前
qq完成签到,获得积分10
3分钟前
思源应助Akitten采纳,获得30
3分钟前
3分钟前
3分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990105
求助须知:如何正确求助?哪些是违规求助? 3532119
关于积分的说明 11256456
捐赠科研通 3271016
什么是DOI,文献DOI怎么找? 1805171
邀请新用户注册赠送积分活动 882288
科研通“疑难数据库(出版商)”最低求助积分说明 809228